Search

Your search keyword '"Gilead Sciences Inc. -- Innovations"' showing total 4 results
Start Over Descriptor "Gilead Sciences Inc. -- Innovations" Journal business wire
4 results on '"Gilead Sciences Inc. -- Innovations"'

1. Gilead's Innovative HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health

Subjects
Gilead Sciences Inc. -- Innovations, Biological products industry -- Innovations, HIV (Viruses) -- Drug therapy, Pipe lines, Public health, AIDS treatment, Business, Business, international, Sunlenca (Medication)
Abstract

- New Positive Clinical Data Demonstrate Momentum on Investigational Once-Daily, Once-Weekly and Twice-Yearly Dosing Strategies - - Key Findings from Studies Evaluating Potential Future Long-Acting Combination Regimens Affirm Commitment to [...]

Published
2024

2. TransCelerate BioPharma Organized for Growth and Bringing New Innovation and Collaboration to the Biopharmaceutical R&D Community

Subjects
Gilead Sciences Inc. -- Innovations, Biological products industry -- Innovations, Chief operating officers, Business, Business, international
Abstract

Gilead Sciences, Inc. Joins Collaborative R&D Consortia PHILADELPHIA -- TransCelerate BioPharma Inc. (TransCelerate), announced today an expansion of its membership and appointment of the organization's Chief Operating Officer. Gilead Sciences, [...]

Published
2024

3. 2022 Hepatitis D Drugs in Development Report - Featuring Antios Therapeutics, CN Bio Innovations, Eiger BioPharmaceuticals and Gilead Sciences Among Others - ResearchAndMarkets.com

Subjects
Merck & Company Inc. -- Innovations, Johnson & Johnson -- Innovations, Gilead Sciences Inc. -- Innovations, GlobeImmune Inc. -- Innovations, Replicor Inc. -- Innovations, Biological products industry -- Innovations, Communicable diseases -- Drug therapy, Biopharmaceutics -- Innovations, Business, Business, international
Abstract

DUBLIN -- The 'Hepatitis D Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update' report has been added to ResearchAndMarkets.com's offering. This report provides [...]

Published
2022

4. Gilead Sciences Demonstrates Commitment to Scientific Innovation In HIV With New Prevention, Treatment and Cure Research Data Presented At AIDS 2020: Virtual

Subjects
United States. Food and Drug Administration -- Innovations, Gilead Sciences Inc. -- Innovations, AIDS (Disease), Emtricitabine -- Innovations, Bictegravir -- Innovations, Dolutegravir, Medical research, Elvitegravir, HIV, Dofetilide -- Innovations, Sexually transmitted disease prevention -- Innovations, Biological products industry -- Innovations, International relief -- United States -- California, Business, Business, international, Descovy (Medication), Biktarvy (Medication)
Abstract

FOSTER CITY, Calif. -- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that new data from the company's HIV research and development program will be presented at the 23rd International AIDS Conference [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results